P09.25 Role of Immune Checkpoint Inhibitors (ICPi) in KRAS-Mutated Non-Small Cell Lung Cancer (NSCLC)

Autor: Peravali, M., Gomes-Lima, C., Tefera, E., Baker, M., Sherchan, M., Farid, S., Burman, K., Constantinescu, F., Veytsman, I.
Zdroj: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S300-S301
Databáze: ScienceDirect